Repligen Corp
NASDAQ:RGEN
Repligen Corp
NASDAQ:RGEN
Price:
173.52 USD
0.6%
Updated:
May 15, 2024
Repligen Corp
Research & Development
|
Repligen Corp
Research & Development Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Repligen Corp
NASDAQ:RGEN
|
Research & Development
-$41.6m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-21%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Research & Development
-$1.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-13%
|
|
|
Danaher Corp
NYSE:DHR
|
Research & Development
-$2.7B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-9%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Research & Development
-$186.2m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-5%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Research & Development
-$453m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-6%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Repligen Corp's Research & Development?
Research & Development
-41.6m
USD
-41.6m
USD
Based on the financial report for Mar 31, 2024, Repligen Corp's Research & Development amounts to -41.6m USD.
What is Repligen Corp's Research & Development growth rate?
Research & Development CAGR 10Y
-21%
-21%
Over the last year, the Research & Development growth was 5%. The average annual Research & Development growth rates for Repligen Corp have been -22% over the past three years , -21% over the past five years , and -21% over the past ten years .
You don't have any saved screeners yet
